EGRP-Supported Health Disparities Research
The National Cancer Institute (NCI) has targeted the reduction of cancer-related health disparities as an important challenge. Health disparities are differences in the incidence, prevalence, mortality, and burden of cancer and related adverse health conditions that exist among specific population groups in the United States. These population groups may be characterized by gender, age, ethnicity, education, income, social class, disability, geographic location, or sexual orientation. The goal is to understand the causes of health disparities in cancer and develop effective interventions to reduce or eliminate them.
NCI-sponsored Funding Opportunity Announcements (FOAs) related to health disparities include:
- Mechanisms of Disparities in Chronic Liver Diseases and Cancer - expires April 5, 2019, unless reissued
- Addressing Health Disparities through Effective Interventions among Immigrant Populations - expires January 8, 2020, unless reissued
- Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations - expires January 8, 2020, unless reissued
- Intervention Research to Improve Native American Health - expires May 15, 2020, unless reissued
- PAR-17-496 (R01)
- U.S. Tobacco Control Policies to Reduce Health Disparities – expires June 16, 2020, unless reissued
- Leveraging Population-based Cancer Registry Data to Study Health Disparities - expires September 8, 2020, unless reissued
- Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) - expires September 11, 2020
- Research on the Health of Transgender and Gender Nonconforming Populations (Clinical Trial Optional) - expires January 8, 2021
- Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (Clinical Trial Not Allowed) - expires March 5, 2021
EGRP joins with other NCI Divisions, Offices, and Centers and other Institutes and Centers at the National Institutes of Health (NIH) to fund grant applications submitted in response to FOAs. View the full list of EGRP FOAs.
EGRP also encourages investigator-initiated grant applications on health disparities topics.
The Epidemiology and Genomics Research Program (EGRP) supports a variety of research addressing health disparities. To learn more about EGRP's health disparities research portfolio, view a list of EGRP's active health disparities grants.
Workshops and Webinars
- Cancer Epidemiologic Research in Understudied Populations Webinar Series (ongoing)
- Think Tank on Understudied Populations in Cancer Epidemiologic Research: Implications for Future Needs (September 2015)
- Prostate Cancer in Men of African Descent: Opportunities for Global Research Collaborations (October 2011)
NCI and NIH resources that may be of interest to investigators interested in health disparities research include:
- Health disparities research in NCI's Division of Cancer Control and Population Sciences
- NCI cancer health disparities portal
- Resources from the NIH Centers to Reduce Cancer Health Disparities
Additionally, NCI's Division of Cancer Control and Population Sciences (DCCPS) offers the following tools to help investigators compare populations with respect to the distribution of risk factors and cancer risk.
- Cancer Mortality Maps
Dynamically generated cancer mortality maps for the time period 1950-2004
- Geographic Information Systems (GIS) and Science for Cancer Prevention and Control
Includes information about tools and data sources to assist in analysis and visualization
- Health Disparities Calculator
Statistical software designed by Surveillance Epidemiology and End Results (SEER) to generate multiple summary measures to evaluate and monitor health disparities
- State Cancer Profiles
Dynamic views of cancer statistics for prioritizing cancer control efforts in the nation, states, and counties
Staff in multiple EGRP Branches are interested in fostering research aimed at reducing cancer-related health disparities. Contacts include:
- Social environment, variation in exposure to environmental toxicants, and biological processes that lead to cancer -
Gary L. Ellison, Ph.D., M.P.H.
- Disparities in health outcomes after cancer diagnosis, cancer survivorship, treatment toxicity -
Lisa Gallicchio, Ph.D.
- Cancer disparities in understudied populations, disparities in carcinogenic risk factors including infectious agents and lifestyle factors -
Tram K. Lam, Ph.D., M.P.H.
- Cancer disparities in underserved populations, cancer epidemiologic research in understudied populations, global health and cancer epidemiology, cancer registry development in the Caribbean -
Damali N. Martin, Ph.D., M.P.H.
- Biomarkers, epigenetics, metabolomics, proteomics, and risk assessment -
Mukesh Verma, Ph.D.